SB1518
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SB1518, covering 2012-04-20 to 2016-06-15. Get the full timeline:
Most recent: Clinical Trial Update: SB1518 for Patients With Myelodysplastic Syndrome (MDS) [Phase 2]